Alcon, Inc. v. Teva Pharmaceuticals USA, Inc.

Federal Circuit

Alcon, Inc. v. Teva Pharmaceuticals USA, Inc.

CourtCourt of Appeals for the Federal Circuit

DecidedJuly 22, 2013

Docket10-1097

StatusUnpublished

This text of Alcon, Inc. v. Teva Pharmaceuticals USA, Inc. (Alcon, Inc. v. Teva Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Alcon, Inc. v. Teva Pharmaceuticals USA, Inc., (Fed. Cir. 2013).

Pincite

Opinion

NOTE: This order is nonprecedential.

Wniteb ~tate~ ~ourt of ~peal~ for tbe jfeberal ~trcutt

ALCON, INC. AND ALCON RESEARCH, LTD., Plaintiffs-Appellees, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant.

2010-1097

Appeal from the United States District Court for the District of Delaware in No. 06-CV-0234, Judge Sue L. Robinson.

ORDER Upon review of the parties' responses to this court's June 10, 2013 order, IT IS ORDERED THAT: (1) The appeal is reactivated. (2) The appellant's opening brief is due within 60 days of the date of this order. ALCON, INC. V. TEVA PHARMACEUTICALS 2

FOR THE COURT

,July 22, 2013 Is/ Daniel E. O'Toole Date Daniel E. O'Toole Clerk

cc: Adam L. Perlman, Esq. Bruce M. Gagala, Esq. FILED U.S. COORT Of APPEAlS FOR THE FEDERAL CIRCUIT s8 JUL 2 2 ZUlJ

DANIEl. E. 07001.E CLERK

Free access — add to your briefcase to read the full text and ask questions with AI